These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Measles antibodies and histocompatibility types in multiple sclerosis. Fewster ME; Ames FR; Botha MC J Neurol Sci; 1979 Sep; 43(1):19-26. PubMed ID: 521827 [TBL] [Abstract][Full Text] [Related]
3. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings. Visscher BR; Sullivan CB; Detels R; Madden DL; Sever JL; Terasaki PI; Park MS; Dudley JP Neurology; 1981 Sep; 31(9):1142-5. PubMed ID: 6267516 [TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants. Poskanzer DC; Sever JL; Terasaki PI; Prenney LB; Sheridan JL; Park MS J Epidemiol Community Health; 1980 Dec; 34(4):265-70. PubMed ID: 7241025 [TBL] [Abstract][Full Text] [Related]
5. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis. Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642 [TBL] [Abstract][Full Text] [Related]
6. HLA types and immunity in multiple sclerosis. Visscher BR; Myers LW; Ellison GW; Malmgren RM; Detels R; Lucia MV; Madden DL; Sever JL; Park MS; Coulson AH Neurology; 1979 Dec; 29(12):1561-5. PubMed ID: 574218 [TBL] [Abstract][Full Text] [Related]
7. Measles antibodies as related to HL-A types in multiple sclerosis. Paty DW; Furesz J; Boucher DW; Rand CG; Stiller CR Neurology; 1976 Jul; 26(7):651-5. PubMed ID: 945513 [TBL] [Abstract][Full Text] [Related]
8. HLA and the immune response to measles in multiple sclerosis. Myers LW; Ellison GW; Fewster ME; Terasaki P; Opelz G Neurology; 1976 Jun; 26(6 PT 2):54-5. PubMed ID: 944896 [No Abstract] [Full Text] [Related]
14. [Correlation between progression of multiple sclerosis and immunogenetic as well as immunological factors]. Cendrowski W Neurol Neurochir Pol; 1978; 12(2):157-60. PubMed ID: 79154 [No Abstract] [Full Text] [Related]
15. The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands. Dean G; Goodall J; Downie A J Epidemiol Community Health; 1981 Jun; 35(2):110-3. PubMed ID: 7299334 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients. Cazzullo CL; Smeraldi E Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585 [No Abstract] [Full Text] [Related]
17. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433 [TBL] [Abstract][Full Text] [Related]
18. HLA-DW2, viral immunity and family studies in multiple sclerosis. Stewart GJ; Basten A; Guinan J; Bashir HV; Cameron J; McLeod JG J Neurol Sci; 1977 Jun; 32(2):153-67. PubMed ID: 874517 [No Abstract] [Full Text] [Related]
19. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7). Trouillas P; Betuel H J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of immunologic and immunogenetic evaluation in multiple sclerosis. Jozefczyk PB; Kelly RH; Rabin BS Immunol Commun; 1984; 13(4):371-9. PubMed ID: 6434406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]